These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 27026089)
1. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer. Lennerz JK; van der Sloot KWJ; Le LP; Batten JM; Han JY; Fan KC; Siegel CA; Srivastava A; Park DY; Chen JH; Sands BE; Korzenik JR; Odze RD; Dias-Santagata D; Borger DR; Khalili H; Iafrate AJ; Lauwers GY Int J Colorectal Dis; 2016 May; 31(5):973-982. PubMed ID: 27026089 [TBL] [Abstract][Full Text] [Related]
2. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor. Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study. Palomba G; Doneddu V; Cossu A; Paliogiannis P; Manca A; Casula M; Colombino M; Lanzillo A; Defraia E; Pazzola A; Sanna G; Putzu C; Ortu S; Scartozzi M; Ionta MT; Baldino G; Sarobba G; Capelli F; Sedda T; Virdis L; Barca M; Gramignano G; Budroni M; Tanda F; Palmieri G J Transl Med; 2016 Oct; 14(1):292. PubMed ID: 27737711 [TBL] [Abstract][Full Text] [Related]
4. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study. Rubio CA; Befrits R Dis Colon Rectum; 1997 Sep; 40(9):1072-8. PubMed ID: 9293938 [TBL] [Abstract][Full Text] [Related]
5. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas. Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990 [TBL] [Abstract][Full Text] [Related]
6. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350 [TBL] [Abstract][Full Text] [Related]
7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer. Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations. Ogura T; Kakuta M; Yatsuoka T; Nishimura Y; Sakamoto H; Yamaguchi K; Tanabe M; Tanaka Y; Akagi K Oncol Rep; 2014 Jul; 32(1):50-6. PubMed ID: 24806883 [TBL] [Abstract][Full Text] [Related]
9. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients. Jin M; Long ZW; Yang J; Lin X Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432 [TBL] [Abstract][Full Text] [Related]
10. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer. Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457 [TBL] [Abstract][Full Text] [Related]
12. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy. Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [TBL] [Abstract][Full Text] [Related]